Search results for " vaccine"
Article
High-Throughput Process Development in an Historical Environment
As an example of their utilization, Chris Daniels from Merck presented work with design and commissioning of a BSL-2 HTS platform for process development of viral vaccine production, where all liquid …
Article
Single-Use Technologies Prove Effective for Viral Vector Process Development
“The simple reality is that the COVID-19 pandemic has shown the benefits of single-use systems in that it would not have been possible to deploy the viral vaccines in the time and the scale that has b…
Article
Single-use Bioreactors Have Reached the Big Time
“Examples include traditional vaccines and blockbuster [monoclonal antibody] (mAb) biologics (>2 metric tons of mAb per year); in these cases, single-use bioreactors might not be the most efficient pr…
Article
Modular Manufacturing Platforms for Biologics
Therapeutic treatments produced via a modular vaccine suite—a pandemic-ready modular facility—could be a good option in the future when dealing with the proliferation of tropical diseases and regional…
Article
Track-and-Trace Progress Benefits Supply-Chain Security Efforts
Since the COVID-19 pandemic struck, there has been little news of serialization breakthroughs, as manufacturers and their supply partners have focused on getting new therapeutics and vaccines to patie…
Article
Process Development: 2020 Reflections and 2021 Possibilities
Last year in particular reenforced the need to reapproach optimization and flexibility for all bioprocesses, as well as emphasized the importance of life-saving products such as vaccines.
To shed …
Article
Scalable Viral Vector Manufacturing
As cost pressure in the biopharma and vaccine industry increase globally, the choice of manufacturing technology is becoming increasingly important. The manufacturing processes and technologies are cr…
Article
Achieving Efficient Adenovirus Upstream Production
Adenovirus is one of the most frequently used viral vectors in the development of therapeutic vaccines and vaccines against infectious diseases. Adenovirus has also been explored as a viral vector f…
Article
Biopharmaceutical Market in Asia: Q&A with Günter Jagschies, Strategic Customer Relations Leader, Cytiva
…biotherapeutic drugs on the high end of the price range as well as even to the much cheaper class of vaccines. Korea, Japan, and Singapore, in particular, have a well-established biopharma industry w…
Article
SEC in the Modern Downstream Purification Process
Governmental pressures to localize vaccine manufacturing in the country of origin also make SEC applications more attractive. The low technical threshold and ease of process development will streamlin…